|Bid||0.4136 x 0|
|Ask||0.4900 x 0|
|Day's Range||0.4070 - 0.4970|
|52 Week Range||0.3352 - 1.8900|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly-owned subsidiary, Emblem Cannabis Corporation, has reached a definitive licensing agreement (the “Agreement”) with Kinstate, Inc. (“Kinstate”) to bring its award-winning, cannabis-infused sublingual strips brand and underlying sublingual strip technology to the Canadian medical and adult-use cannabis market. The Agreement provides the Company with the exclusive Canadian rights to manufacture, market and sell certain Kin Slips products, along with rights to use the associated proprietary formulations, manufacturing methodology and intellectual property provided by Kinstate and options for the Company to offer the format into certain other international markets.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has received an update from a third-party transportation company (the “Carrier”) regarding a shipment of Aleafia Health’s packaged, finished cannabis products intended for the adult-use market. The authorized Carrier was in possession of the Company’s cannabis products and was contracted to deliver the shipment to provincial wholesale facilities in the next week. On December 20, 2019 the Carrier notified Aleafia Health that the transportation vehicle containing the shipment had been reported stolen from the Carrier’s facility.
A cannabis brand backed by Drake's producer is getting ready to launch expensive, luxury pot in the spring. Analysts warn of knock-offs and weak demand.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) cannabis education division, FoliEdge Academy Inc., has entered into a definitive Educational Products Distribution Agreement with Seneca to develop and deliver new courses and programs focused on aspects of the cannabis industry in Canada. It is with the goal of meeting this need by delivering top quality education that FoliEdge Academy has aligned with Seneca, a leading postsecondary institution in Ontario that is continuously innovating and developing new content for its students and stakeholders.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has reached a definitive Cannabis Material Purchase Agreement (the “Agreement”) on November 29, 2019, with a Canadian Licensed Producer. Under the terms of the Agreement, Aleafia Health will sell 2,840 kg of dried cannabis flower at a price per gram of $2.50, generating $7.1 million in revenue. The dried flower was cultivated at Aleafia Health’s Port Perry Outdoor Grow facility, which yielded 10,300 kg in 2019.
MELBOURNE, Australia, Nov. 29, 2019 -- Montu Group Pty. Ltd (“Montu Group” or the “Company”), a leading medical cannabis company with presence in Europe and Asia-Pacific, is.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed production of its first white label production run of medical cannabis oils, for distribution in Australia. The cannabis oils were produced at the Company’s Paris Processing Facility and will be distributed by Melbourne, Australia based Montu Group Pty. Ltd. (“Montu Group”), leveraging their newly launched premium medical brand Circle. The transaction represents the first production run of Aleafia Health’s newly launched international white label production service, which leverages the Company’s proven formulas and international distribution channels.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly-owned subsidiary FoliEdge Academy, has entered into an Educational Products Distribution Agreement with one of the largest Canadian post-secondary institutions to introduce cannabis education courses and programs. FoliEdge Academy is an interactive cannabis education and certification platform, featuring proprietary, interactive courses customized for large organizations. FoliEdge Academy course content forms an important element of Aleafia Health’s scalable cannabis health and wellness ecosystem, integrating with the Company’s medical cannabis clinic network with 70,000 patients seen to date.
If you’re looking for bargain stocks this November, Aleafia stock, Baytex stock, and Corby stock are great choices. Each company is in a slump but is well positioned for recovery in 2020.
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Emblem Cannabis Corp., has secured two Health Canada licence amendments that expand processing capacity, allowing for the sale of new product formats at its Paris Processing facility. The amendments apply to the licensed and operational Paris location, which processes all of the Company’s extraction, packaging and order fulfilment for Canadian and international sales.
Ultra low-cost production at $0.08 cost per gram at outdoor facilityAverage net revenue per gram equivalent of $15.11 for medical cannabis salesMedical cannabis sales up 43%.
Cannabinoid content per gram only slightly lower than identical strains grown indoorsCritical quality control tests successfulApproximately 1,000 kg yield per acre in Zone.
TORONTO, Oct. 23, 2019 -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 Third Quarter Financial Results on November 12,.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that it has provided Aphria Inc. (TSX: APHA, NYSE: APHA) (“Aphria”) with a formal notice of the termination, effective October 7, 2019, of the wholesale cannabis supply agreement (the “Supply Agreement”) dated September 11, 2018 between Aphria and Emblem Corp. (“Emblem”), a wholly-owned subsidiary of the Company, providing for the provision by Aphria of up to 175,000 kg equivalents of cannabis products over an initial five-year term, commencing May 1, 2019.
Features initial 115,000 kg of dried flower equivalent annual extraction capacity, with ability for further expansion on-site2,775% increase over Company’s current annual.
TORONTO, Oct. 02, 2019 -- The Board of Directors of Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has appointed Lea Ray as its new.
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to provide guidance anticipating the Company will achieve positive net income for the three month period ended September 30, 2019. “Through prudent capital allocation, coupled with strong cannabis revenue growth, we now expect to deliver the first profitable quarter in Aleafia Health’s history, a major milestone. This will mark our second consecutive quarter featuring both substantial expense reductions and increased revenues as we continue to drive towards sustainable, compliant growth that will deliver real benefits to our stakeholders,” said Aleafia Health CEO Geoffrey Benic.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”)’s wholly owned subsidiary, Aleafia Farms Inc., has acquired the farmland directly adjacent to its Port Perry Outdoor Grow facility. The purchase will allow the Company to commence its Outdoor Grow Phase II expansion, adding an additional 60 acres of cannabis cultivation area, for a total of 86 acres.
Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) is pleased to provide a corporate update and report its Second Quarter 2019 financial results for the period ended June 30, 2019. Aleafia Health has filed its consolidated financial statements and related management’s discussion and analysis, both of which are available on Aleafia Health’s profile at www.SEDAR.com. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “The foundation that our team has built over the last year is now beginning to prove its worth as we report marked improvements with record revenue generated, significant cost reductions and a growing base of active, registered medical cannabis patients,” said Aleafia Health CEO Geoffrey Benic.